Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontranscription coregulator activity

MED15 NCOR1 MYOCD KMT2D MRTFA

5.86e-05562165GO:0003712
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

MED15 NCOR1 MYOCD KMT2D MRTFA NOS1AP

1.83e-041160166GO:0030674
GeneOntologyMolecularFunctionmolecular adaptor activity

MED15 NCOR1 MYOCD KMT2D MRTFA NOS1AP

4.29e-041356166GO:0060090
GeneOntologyMolecularFunctiontranscription coactivator activity

MYOCD KMT2D MRTFA

1.67e-03303163GO:0003713
GeneOntologyBiologicalProcessregulation of miRNA transcription

POU2F1 NCOR1 MYOCD MRTFA

4.28e-0783164GO:1902893
GeneOntologyBiologicalProcessmiRNA transcription

POU2F1 NCOR1 MYOCD MRTFA

4.49e-0784164GO:0061614
GeneOntologyBiologicalProcessregulation of miRNA metabolic process

POU2F1 NCOR1 MYOCD MRTFA

1.02e-06103164GO:2000628
GeneOntologyBiologicalProcessmiRNA metabolic process

POU2F1 NCOR1 MYOCD MRTFA

1.82e-06119164GO:0010586
GeneOntologyBiologicalProcesspositive regulation of miRNA transcription

POU2F1 MYOCD MRTFA

1.34e-0561163GO:1902895
GeneOntologyBiologicalProcesspositive regulation of miRNA metabolic process

POU2F1 MYOCD MRTFA

2.30e-0573163GO:2000630
GeneOntologyCellularComponentnuclear protein-containing complex

MED15 POU2F1 NCOR1 MYOCD KMT2D PHF21A

2.41e-041377156GO:0140513
GeneOntologyCellularComponenttranscription regulator complex

MED15 POU2F1 NCOR1 MYOCD

6.95e-04596154GO:0005667
GeneOntologyCellularComponentRNA polymerase II transcription regulator complex

MED15 POU2F1 MYOCD

8.83e-04272153GO:0090575
GeneOntologyCellularComponenthistone deacetylase complex

NCOR1 PHF21A

1.66e-0385152GO:0000118
GeneOntologyCellularComponentchromatin

FOXP2 POU2F1 NCOR1 MYOCD POU6F2

2.91e-031480155GO:0000785
DomainRPEL

MYOCD MRTFA

1.44e-057162PS51073
DomainRPEL

MYOCD MRTFA

1.44e-057162PF02755
DomainRPEL_repeat

MYOCD MRTFA

1.44e-057162IPR004018
DomainRPEL

MYOCD MRTFA

1.44e-057162SM00707
DomainPOU_3

POU2F1 POU6F2

8.20e-0516162PS51179
DomainPOU_1

POU2F1 POU6F2

8.20e-0516162PS00035
DomainPOU

POU2F1 POU6F2

8.20e-0516162SM00352
DomainPOU_2

POU2F1 POU6F2

8.20e-0516162PS00465
DomainPou

POU2F1 POU6F2

8.20e-0516162PF00157
DomainRmlC_Cupin

CIZ1 FOXP2

8.20e-0516162IPR011051
DomainPOU_dom

POU2F1 POU6F2

8.20e-0516162IPR000327
DomainPOU

POU2F1 POU6F2

9.29e-0517162IPR013847
Domain-

MYOCD MRTFA

1.43e-04211621.10.720.30
DomainSAP

MYOCD MRTFA

1.57e-0422162PF02037
DomainSAP

MYOCD MRTFA

1.72e-0423162SM00513
DomainSAP

MYOCD MRTFA

2.04e-0425162PS50800
DomainSAP_dom

MYOCD MRTFA

2.04e-0425162IPR003034
Domain-

POU2F1 POU6F2

2.39e-04271621.10.260.40
DomainLambda_DNA-bd_dom

POU2F1 POU6F2

2.76e-0429162IPR010982
Domain-

POU2F1 NCOR1 POU6F2

1.67e-032831631.10.10.60
DomainPHD

KMT2D PHF21A

1.84e-0375162PF00628
DomainZnf_PHD-finger

KMT2D PHF21A

2.04e-0379162IPR019787
DomainPHD

KMT2D PHF21A

2.58e-0389162SM00249
DomainHomeodomain-like

POU2F1 NCOR1 POU6F2

2.62e-03332163IPR009057
DomainZnf_PHD

KMT2D PHF21A

2.70e-0391162IPR001965
DomainZF_PHD_2

KMT2D PHF21A

2.93e-0395162PS50016
DomainZF_PHD_1

KMT2D PHF21A

2.99e-0396162PS01359
DomainZnf_FYVE_PHD

KMT2D PHF21A

6.87e-03147162IPR011011
DomainHomeobox

POU2F1 POU6F2

1.67e-02234162PF00046
DomainHOMEOBOX_1

POU2F1 POU6F2

1.70e-02236162PS00027
DomainHOX

POU2F1 POU6F2

1.71e-02237162SM00389
DomainHomeobox_dom

POU2F1 POU6F2

1.74e-02239162IPR001356
DomainHOMEOBOX_2

POU2F1 POU6F2

1.74e-02239162PS50071
DomainZINC_FINGER_C2H2_1

CIZ1 ZNF853 FOXP2

2.68e-02777163PS00028
DomainRING

KMT2D PHF21A

2.74e-02305162SM00184
DomainZnf_C2H2-like

CIZ1 ZNF853 FOXP2

2.85e-02796163IPR015880
DomainZnf_C2H2

CIZ1 ZNF853 FOXP2

2.94e-02805163IPR007087
DomainZnF_C2H2

CIZ1 ZNF853 FOXP2

2.96e-02808163SM00355
DomainZnf_RING

KMT2D PHF21A

3.10e-02326162IPR001841
Pubmed

Interaction network of human early embryonic transcription factors.

MED15 FOXP2 POU2F1 NCOR1 KMT2D PHF21A

1.14e-0835117638297188
Pubmed

cDNAs with long CAG trinucleotide repeats from human brain.

MED15 FOXP2 KMT2D

1.71e-07231739225980
Pubmed

Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.

MYOCD MRTFA

2.25e-07217214970199
Pubmed

Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.

MYOCD MRTFA

2.25e-07217231928221
Pubmed

RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding.

MYOCD MRTFA

6.74e-07317218025109
Pubmed

Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice.

MYOCD MRTFA

6.74e-07317223103763
Pubmed

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

MYOCD MRTFA

6.74e-07317211439182
Pubmed

Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation.

MYOCD MRTFA

6.74e-07317217363709
Pubmed

Myocardin-related transcription factor contributes to renal fibrosis through the regulation of extracellular microenvironment surrounding fibroblasts.

MYOCD MRTFA

6.74e-07317237289107
Pubmed

The histone demethylase, Jmjd1a, interacts with the myocardin factors to regulate SMC differentiation marker gene expression.

MYOCD MRTFA

1.35e-06417217991879
Pubmed

Potentiation of serum response factor activity by a family of myocardin-related transcription factors.

MYOCD MRTFA

1.35e-06417212397177
Pubmed

Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation.

MYOCD MRTFA

1.35e-06417216204380
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

CIZ1 FOXP2 POU2F1 NCOR1 PHF21A MRTFA

1.53e-0680817620412781
Pubmed

Thymine DNA glycosylase represses myocardin-induced smooth muscle cell differentiation by competing with serum response factor for myocardin binding.

MYOCD MRTFA

2.25e-06517218945672
Pubmed

Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation.

MYOCD MRTFA

2.25e-06517217360478
Pubmed

Muscle-specific signaling mechanism that links actin dynamics to serum response factor.

MYOCD MRTFA

2.25e-06517215798203
Pubmed

PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells.

MED15 KMT2D PHF21A

4.16e-066517322496869
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

MED15 NCOR1 KMT2D PHF21A

7.58e-0626817433640491
Pubmed

Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors.

POU2F1 NCOR1

8.08e-06917211891224
Pubmed

Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

POU2F1 NCOR1 KMT2D

8.70e-068317328794006
Pubmed

Spinal Inhibitory Interneuron Diversity Delineates Variant Motor Microcircuits.

FOXP2 POU6F2

1.01e-051017226949184
Pubmed

Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function.

MYOCD MRTFA

1.75e-051317229114040
Pubmed

The transcription factor Foxf1 binds to serum response factor and myocardin to regulate gene transcription in visceral smooth muscle cells.

MYOCD MRTFA

1.75e-051317223946491
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

POU2F1 NCOR1 KMT2D MRTFA MINK1

2.67e-0577417515302935
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

CIZ1 MED15 KMT2D PHF21A

3.57e-0539817435016035
Pubmed

Human transcription factor protein interaction networks.

MED15 FOXP2 POU2F1 NCOR1 KMT2D PHF21A

3.99e-05142917635140242
Pubmed

The histone H3-lysine 4-methyltransferase Mll4 regulates the development of growth hormone-releasing hormone-producing neurons in the mouse hypothalamus.

FOXP2 KMT2D

4.25e-052017233431871
Pubmed

Myocardin regulates BMP10 expression and is required for heart development.

MYOCD MRTFA

4.25e-052017222996691
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

NCOR1 KMT2D PHF21A MRTFA

4.32e-0541817434709266
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

FOXP2 POU2F1 NCOR1 KMT2D PHF21A

4.34e-0585717525609649
Pubmed

Embryonic temporal-spatial delineation of excitatory spinal V3 interneuron diversity.

FOXP2 POU6F2

5.16e-052217238160393
Pubmed

A radial glia-specific role of RhoA in double cortex formation.

FOXP2 MRTFA

5.66e-052317222405202
Pubmed

Hemodynamic force is required for vascular smooth muscle cell recruitment to blood vessels during mouse embryonic development.

MYOCD MRTFA

6.17e-052417230796970
Pubmed

Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression.

MYOCD MRTFA

6.70e-052517220019329
Pubmed

Genome-wide characterisation of Foxa1 binding sites reveals several mechanisms for regulating neuronal differentiation in midbrain dopamine cells.

FOXP2 POU6F2

9.70e-053017225804738
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

FMN2 NCOR1 KMT2D MINK1 NOS1AP

1.13e-04104917527880917
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

CIZ1 MED15 NCOR1 KMT2D

1.24e-0454917438280479
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

MED15 POU2F1 NCOR1 KMT2D PHF21A

1.43e-04110317534189442
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

CIZ1 FOXP2 FMN2 PHF21A NOS1AP

1.51e-04111617531753913
Pubmed

Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse.

KMT2D MRTFA

1.56e-043817227930960
Pubmed

Phox2a Defines a Developmental Origin of the Anterolateral System in Mice and Humans.

FOXP2 POU6F2

1.73e-044017233238113
Pubmed

Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.

FOXP2 POU2F1 PHF21A

2.69e-0426317320932939
Pubmed

TBX2 and TBX3 act downstream of canonical WNT signaling in patterning and differentiation of the mouse ureteric mesenchyme.

FOXP2 MYOCD

2.83e-045117230478225
Pubmed

CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.

NCOR1 PHF21A

3.05e-045317234026424
Pubmed

Genome-wide atlas of gene expression in the adult mouse brain.

NCOR1 POU6F2

3.17e-045417217151600
Pubmed

Mice lacking DYRK2 exhibit congenital malformations with lung hypoplasia and altered Foxf1 expression gradient.

FOXP2 MYOCD

3.53e-045717234671097
Pubmed

Homologs of genes expressed in Caenorhabditis elegans GABAergic neurons are also found in the developing mouse forebrain.

NCOR1 POU6F2

3.53e-045717221122108
InteractionFEV interactions

FOXP2 POU2F1 NCOR1 KMT2D PHF21A

3.94e-07203165int:FEV
InteractionRELA interactions

MED15 POU2F1 GLG1 POU6F2 KMT2D MRTFA

1.23e-06485166int:RELA
InteractionTLX2 interactions

POU2F1 NCOR1 POU6F2 KMT2D

4.03e-06142164int:TLX2
InteractionSOX5 interactions

FOXP2 POU2F1 NCOR1 KMT2D

6.79e-06162164int:SOX5
InteractionEGR2 interactions

FOXP2 NCOR1 KMT2D PHF21A

8.41e-06171164int:EGR2
InteractionMRTFA interactions

MYOCD PHF21A MRTFA

1.37e-0560163int:MRTFA
InteractionCRX interactions

MED15 FOXP2 POU2F1 KMT2D

3.98e-05254164int:CRX
InteractionGSC interactions

FOXP2 POU2F1 KMT2D

4.18e-0587163int:GSC
InteractionSOX10 interactions

NCOR1 POU6F2 KMT2D

4.94e-0592163int:SOX10
InteractionSOX17 interactions

POU2F1 NCOR1 KMT2D

5.44e-0595163int:SOX17
InteractionTLX3 interactions

POU2F1 NCOR1 POU6F2 KMT2D

6.76e-05291164int:TLX3
InteractionHCFC1 interactions

MED15 POU2F1 NCOR1 KMT2D

6.94e-05293164int:HCFC1
InteractionZFHX3 interactions

POU2F1 POU6F2 PHF21A

8.19e-05109163int:ZFHX3
InteractionTBR1 interactions

FOXP2 NCOR1 KMT2D

9.11e-05113163int:TBR1
InteractionPAX7 interactions

POU2F1 NCOR1 KMT2D

1.20e-04124163int:PAX7
InteractionPAX6 interactions

POU2F1 NCOR1 KMT2D PHF21A

1.64e-04366164int:PAX6
InteractionFHL2 interactions

NCOR1 POU6F2 PHF21A MRTFA

2.22e-04396164int:FHL2
InteractionMYOCD interactions

MYOCD MRTFA

2.37e-0429162int:MYOCD
InteractionS100A2 interactions

FOXP2 POU2F1 KMT2D MRTFA

2.58e-04412164int:S100A2
InteractionAVPR1B interactions

FMN2 MINK1

3.08e-0433162int:AVPR1B
InteractionGPC6 interactions

MINK1 CLEC12B

3.27e-0434162int:GPC6
InteractionLHX2 interactions

NCOR1 KMT2D MRTFA

3.78e-04183163int:LHX2
InteractionNUP62CL interactions

POU6F2 PHF21A

3.87e-0437162int:NUP62CL
InteractionHIVEP1 interactions

POU2F1 POU6F2 PHF21A

3.97e-04186163int:HIVEP1
InteractionNFIA interactions

MED15 NCOR1 KMT2D

4.09e-04188163int:NFIA
InteractionCCNC interactions

MED15 FOXP2 POU6F2

4.09e-04188163int:CCNC
InteractionHNF1B interactions

NCOR1 POU6F2 KMT2D

4.22e-04190163int:HNF1B
InteractionMYOD1 interactions

NCOR1 MYOCD KMT2D

4.48e-04194163int:MYOD1
InteractionFOXL1 interactions

POU2F1 NCOR1 KMT2D

4.62e-04196163int:FOXL1
InteractionRCOR1 interactions

NCOR1 KMT2D PHF21A MRTFA

5.13e-04494164int:RCOR1
InteractionNFIC interactions

POU2F1 NCOR1 KMT2D

5.65e-04210163int:NFIC
InteractionSP4 interactions

FOXP2 POU2F1

5.99e-0446162int:SP4
InteractionOIP5 interactions

POU6F2 PHF21A NOS1AP

6.22e-04217163int:OIP5
InteractionNR1I3 interactions

MED15 NCOR1

6.53e-0448162int:NR1I3
InteractionNCOA3 interactions

NCOR1 MYOCD MRTFA

6.82e-04224163int:NCOA3
InteractionNFIX interactions

POU2F1 NCOR1 KMT2D

7.09e-04227163int:NFIX
InteractionFOXC1 interactions

FOXP2 POU2F1 NCOR1

7.18e-04228163int:FOXC1
InteractionKLF3 interactions

NCOR1 KMT2D PHF21A

7.18e-04228163int:KLF3
InteractionMLLT10 interactions

POU2F1 POU6F2

7.37e-0451162int:MLLT10
InteractionL3MBTL2 interactions

CIZ1 POU6F2 PHF21A

7.45e-04231163int:L3MBTL2
InteractionAR interactions

MED15 POU2F1 NCOR1 KMT2D PHF21A

7.93e-04992165int:AR
InteractionTPRX2 interactions

NCOR1 KMT2D

8.88e-0456162int:TPRX2
InteractionMRTFB interactions

PHF21A MRTFA

9.19e-0457162int:MRTFB
InteractionNR2F1 interactions

FOXP2 POU2F1

9.52e-0458162int:NR2F1
InteractionTSEN15 interactions

POU6F2 MINK1

1.09e-0362162int:TSEN15
InteractionPPIP5K2 interactions

POU2F1 POU6F2

1.12e-0363162int:PPIP5K2
InteractionNPAT interactions

POU2F1 PHF21A

1.16e-0364162int:NPAT
InteractionBAG2 interactions

CIZ1 POU2F1 NCOR1 MRTFA

1.22e-03622164int:BAG2
InteractionNUP43 interactions

CIZ1 NCOR1 KMT2D PHF21A

1.24e-03625164int:NUP43
InteractionKDM3A interactions

MYOCD MRTFA

1.27e-0367162int:KDM3A
InteractionGCM1 interactions

NCOR1 KMT2D

1.31e-0368162int:GCM1
InteractionHDAC1 interactions

POU2F1 NCOR1 KMT2D PHF21A MRTFA

1.31e-031108165int:HDAC1
InteractionKDM4B interactions

NCOR1 KMT2D

1.42e-0371162int:KDM4B
InteractionKLF15 interactions

MED15 NCOR1 KMT2D

1.44e-03290163int:KLF15
InteractionZFHX4 interactions

FOXP2 PHF21A

1.50e-0373162int:ZFHX4
InteractionHSPA4 interactions

POU2F1 NCOR1 MYOCD POU6F2

1.57e-03667164int:HSPA4
InteractionSP7 interactions

POU2F1 NCOR1 KMT2D

1.65e-03304163int:SP7
InteractionNFKB1 interactions

POU2F1 NCOR1 GLG1

1.69e-03307163int:NFKB1
InteractionCT45A5 interactions

GLG1 NOS1AP

1.71e-0378162int:CT45A5
InteractionC11orf52 interactions

FMN2 MINK1 NOS1AP

1.76e-03311163int:C11orf52
InteractionGPC4 interactions

MINK1 CLEC12B

1.76e-0379162int:GPC4
InteractionHNF1A interactions

POU2F1 KMT2D

1.80e-0380162int:HNF1A
InteractionMANF interactions

FMN2 KMT2D

1.80e-0380162int:MANF
InteractionPKNOX1 interactions

POU2F1 MINK1

1.89e-0382162int:PKNOX1
InteractionSOX7 interactions

KMT2D PHF21A

1.89e-0382162int:SOX7
Cytoband17p11.2

NCOR1 MYOCD

1.57e-0315917217p11.2
CytobandEnsembl 112 genes in cytogenetic band chr9q34

CIZ1 FAM157B

6.33e-03325172chr9q34
GeneFamilyAtaxins|Trinucleotide repeat containing

MED15 FOXP2 KMT2D

2.78e-0725103775
GeneFamilyPOU class homeoboxes and pseudogenes

POU2F1 POU6F2

6.92e-0523102523
GeneFamilyPHD finger proteins

KMT2D PHF21A

1.07e-039010288
CoexpressionNIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER

FOXP2 POU2F1

8.25e-0521172M10991
CoexpressionLAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB

FOXP2 PHF21A NOS1AP

1.68e-04169173M39230
CoexpressionGSE37532_WT_VS_PPARG_KO_LN_TREG_UP

CIZ1 POU2F1 MINK1

1.89e-04176173M8952
CoexpressionGSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP

KMT2D PHF21A MRTFA

2.67e-04198173M7948
CoexpressionGSE27786_BCELL_VS_ERYTHROBLAST_UP

NCOR1 KMT2D MRTFA

2.75e-04200173M4810
CoexpressionGSE31082_DN_VS_CD8_SP_THYMOCYTE_DN

FOXP2 NCOR1 KMT2D

2.75e-04200173M5063
CoexpressionGSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP

GLG1 PHF21A MINK1

2.75e-04200173M5787
CoexpressionGSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN

GLG1 PHF21A MRTFA

2.75e-04200173M7658
CoexpressionGSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP

CIZ1 MED15 PHF21A

2.75e-04200173M4301
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Mup5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 MYOCD POU6F2

1.45e-051271736df92f80b8922ca00eb383f79cd8dda4d602adfc
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 MYOCD POU6F2

1.59e-0513117381efe8b0ca4377e557a42ddb12aecaf3f46b15bf
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 MYOCD POU6F2

1.98e-051411735ef3166c5271aa90fd0633016edfe2c74b835319
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 MYOCD NOS1AP

2.43e-05151173f50c5ae9dae507df750df25e151b58685fec70ce
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FOXP2 FMN2 MYOCD

3.53e-05171173fe0665c5ca01b0b2cc8f20d64587f0847c3d215c
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 MYOCD POU6F2

3.78e-05175173d4827b4dfad07f11cbdd47fbed287af1afb9b1b8
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FOXP2 FMN2 MYOCD

3.84e-05176173a8875b4ba4abf6625cdeb67bf544ce1573c59060
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FOXP2 FMN2 MYOCD

4.39e-05184173590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FOXP2 FMN2 MYOCD

4.83e-05190173e102622f05c7f3e1bd8b224ea159d57033793ee0
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FOXP2 FMN2 MYOCD

4.90e-05191173de2cd94ee88a7754f86d39469e38374d668210c7
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 FMN2 POU6F2

5.21e-051951732e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-COL22A1--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic

FOXP2 MYOCD POU6F2

5.62e-0520017342aa70483ea8ca7b7b80831356c9ded82841b941
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-COL22A1|Neuronal / cells hierarchy compared to all cells using T-Statistic

FOXP2 MYOCD POU6F2

5.62e-05200173ac1ce87f8a79926029e77d3912cd5edfb7aa8202
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-COL22A1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

FOXP2 MYOCD POU6F2

5.62e-05200173e87c02fbb0d85de7e63c98b7fc2aca424feeeedc
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e-Excitatory_Neuron.Sc17a7.Sema3e-Nnat_(Layer_6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

ZNF853 POU6F2

4.93e-04871727518ca56d626619d9706505169a85f1850105608
ToppCell(04)_Pre-ciliated-(4)_1wkpi|(04)_Pre-ciliated / shred by cell type and Timepoint

MYOCD MINK1

5.16e-0489172846c2fec66981bf41be64a2e1812ec1b1b833961
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 MYOCD

9.35e-041201722b7596946f9268c4202348adf3069decd8313bb0
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FOXP2 NOS1AP

1.05e-031271725b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 NOS1AP

1.10e-0313017205d5a73acf1d7f75a79876b1a06d27c74a89b8a4
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 MYOCD

1.13e-0313217266ec5a06eece27c0aafb548f51db9fee595e71bc
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7|TCGA-Stomach / Sample_Type by Project: Shred V9

FOXP2 MYOCD

1.18e-03135172451e90c154e26ae4f72269d6765e7ef51d67313a
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

FOXP2 POU2F1

1.18e-031351723351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCellCOVID-19_Severe-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class

FAM157B MYOCD

1.20e-03136172e272d11bb52f890f6681cc9384aeac27976ec650
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FAM157B MYOCD

1.21e-0313717212caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be
ToppCellCOVID-19_Severe-Classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class

FAM157B MYOCD

1.27e-03140172cade44740dd3acca7789591aa5a7935d48d5cbee
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9

FOXP2 MYOCD

1.29e-031411721baa054c2ae3b446d1954244b7fbf8af824ef345
ToppCellpdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

KMT2D MRTFA

1.34e-031441720b94d978262a826c9254145aa98c6c30240243f9
ToppCellFrontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

FOXP2 POU6F2

1.45e-031501729d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FMN2 MYOCD

1.47e-03151172523dcd243c285a6b74830a93c82cca8784edd658
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FMN2 MYOCD

1.47e-03151172f3406094ce79cc80398b82d58ca6fd87a96e68d4
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FMN2 MYOCD

1.49e-031521720cb5f4dfae04e3f4eba502bbf229007d5fa3884d
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FMN2 MYOCD

1.49e-03152172ba89ffb5a8bb33c188f854f54b39123b6d73496a
ToppCellFrontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

FOXP2 POU6F2

1.51e-03153172b37a1ecad389d2848b8ca4d287823e8048207420
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 NOS1AP

1.53e-0315417212cbc38bc1f7231c67e1d2d5e86e95bc12e24682
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 NOS1AP

1.57e-03156172fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FMN2 POU6F2

1.57e-03156172dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FMN2 POU6F2

1.57e-03156172abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CYP26B1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MYOCD CLEC12B

1.63e-03159172edc193187fedaf5b1d8891231cf862a177eafb64
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXP2 MYOCD

1.65e-03160172c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXP2 MYOCD

1.65e-0316017225c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 NOS1AP

1.69e-0316217258da6bc04cdac0002b0e6a751c96ff95e1a7f70f
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 NOS1AP

1.69e-031621724d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXP2 NOS1AP

1.71e-03163172b0aa4a620bd58011225b42ea6dda04e3101ba342
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.75e-03165172ee48ca87aed7c19a26c0ae42ce6a6f51b2fe3b8b
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXP2 NOS1AP

1.75e-031651721b7dfa173e83aa8c46a3153a3261866c065c3b73
ToppCell15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

FOXP2 MYOCD

1.75e-03165172531804467601e1ee1f771cffa21501f6d464ae10
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXP2 NOS1AP

1.75e-03165172b4f7d33af7d053ec07b01bd67d861600a9c4822e
ToppCell356C-Epithelial_cells-Epithelial-D_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells)

FOXP2 NOS1AP

1.77e-03166172eb8d972326a734549675307e411fc795af66da70
ToppCell356C-Epithelial_cells-Epithelial-D_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells)

FOXP2 NOS1AP

1.77e-031661722e4cb4056e6b0c43290a5588ff525f5f05b8beee
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 MYOCD

1.82e-031681724a2e08b047f7170ae4b95eac9b2b128e55beee4a
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32

MRTFA NOS1AP

1.82e-031681726db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCellTCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9

FOXP2 MYOCD

1.82e-03168172a97e8e07ba949b30805aeed5f60fa5e092b9d3d4
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 MYOCD

1.82e-031681723e09516e819cf140a6dbf8f85247d3f08aa35bb8
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.82e-031681721d58731a481ecac84c15affa84f8041dd67d944c
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.84e-03169172319cba07263bf41fcbcbfecd117f91b729394241
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.86e-0317017249fc45d8a5c3ad89d1649fa46d7a285891379392
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 NOS1AP

1.86e-03170172417b77c12a7982b1ce4b4bc57f30335d261220f5
ToppCellTCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9

FOXP2 MYOCD

1.86e-03170172516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f
ToppCellCOVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

MYOCD CLEC12B

1.86e-031701724232fe937909f93d3736988c707b8f95ce993398
ToppCellTCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9

FOXP2 MYOCD

1.86e-03170172cdc19013da7c41d1ed8400a6a643e4c684ff9912
ToppCellTCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9

FOXP2 MYOCD

1.86e-031701720bde0a40440c7fdf7ba89cac8831d4014e7a4807
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.86e-0317017287cac555f16b6c2ef3d1b3a00f992d8bf2237b50
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.86e-031701723174ea9cf93892a8b41de10fd4ff6f06bb41502d
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.86e-031701725de2f7d16a05af74ebfb1ca42d0f9c3c3524692d
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 MYOCD

1.88e-031711720417fa805ca0acb7e9f6a30bc7b6bdbaba77844d
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

PHF21A MRTFA

1.88e-031711722b7c5a557c4bc5c573211c4d618bdd6766a24916
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.88e-03171172f648789e6aefe508bb748401bf9b3cd830fb0ddf
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

PHF21A MRTFA

1.88e-03171172dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.88e-031711726a489a75eeab2a2d48d604682e93599c20a945fe
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.88e-031711729d5cabd71a901a00eb16c4d151189296f1b3bf6f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.90e-0317217241ddfb316429efef5f3fa0b0621ced383d9206f0
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.90e-0317217292e76cbf4807704790f42cf2507e92f85cd3bc92
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FOXP2 NOS1AP

1.90e-031721721565f38266891c3acf49778838de134c5dee5460
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.90e-0317217218bdf34e1b94dcb1daf00c533e3ce1a8d67fcc0e
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.92e-031731724ec147479b359cce1975d57a50ee1437a0e1e663
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.92e-031731728335b77f730ed43fc348a005566e73a103c6774b
ToppCelldroplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXP2 CLEC12B

1.92e-0317317260e427f6c7d953cef5f692043670ff0b49cdce72
ToppCell5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYOCD NOS1AP

1.92e-03173172f8e3dded726bb3a6c24bfedf8c6732bb46262308
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.92e-031731725aa4d45a01d2d09eff8b4deb32bd91ab2471210a
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.92e-03173172ee972d9cc68755926512fd3bbe1267098c67cd94
ToppCelldroplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

POU2F1 CLEC12B

1.92e-0317317266488d01e03264fb193285470901c9c4182fbae8
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.92e-031731729a2d42f8d9cb834856522661d524abb91c4637c5
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.95e-031741722947e5906b172d149412fa4e77476fce4ea695d2
ToppCellfacs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FMN2 MYOCD

1.95e-0317417232fdeeebeeeca657eac6329caad4c28ca54e4d1c
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.95e-03174172df5664da3b93c233509781429a9c6d7edf1b8944
ToppCellfacs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FMN2 MYOCD

1.95e-03174172eb8012823b08729b462d1e5212f4873bb6b4eb1e
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 NOS1AP

1.95e-03174172e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FOXP2 NOS1AP

1.95e-031741723f0a5ce074675d57d479fa069385a1b3071e884e
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FMN2 NOS1AP

1.95e-03174172271c51d220842402975d97c86c9acfdbdf62a32c
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FOXP2 NOS1AP

1.95e-03174172d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.97e-0317517206af6629766e2054e6995e8cdb3907658fec49d3
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.97e-03175172030f93af5a96848b9118e2a8116e19ddae438d92
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FOXP2 NOS1AP

1.97e-03175172e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

POU6F2 NOS1AP

1.99e-031761720710689e66deba179b0a8038cdd56b4834984f12
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

1.99e-03176172cd4b9211652596c42e7af318bcd464681daebb10
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

2.01e-0317717201df8ab3285fa66b4805c555cfbfc4b3b16db919
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

2.01e-03177172b6476a91abd06b8271b4d0ad7431d24b44022b47
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

2.01e-03177172921783ed0fe20294d2f384d9136924b679df01bb
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 POU6F2

2.01e-031771727e799333307448c6a94d1f33dbc59c543336f45e
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FOXP2 NOS1AP

2.01e-031771724c069f0d044a96118090b85ca592a21d6b5d9399
DrugTiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A

CIZ1 MRTFA MINK1 NOS1AP

8.07e-061911642840_UP
DrugCephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A

CIZ1 GLG1 MRTFA MINK1

8.94e-061961644826_DN
DrugPipemidic acid [51940-44-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A

CIZ1 GLG1 MRTFA MINK1

9.49e-061991646470_DN
DrugAlthiazide [5588-16-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A

MED15 NCOR1 MRTFA MINK1

9.68e-062001646829_DN
DrugAC1OC6D1

POU2F1 NCOR1 PHF21A

4.97e-05104163CID006368594
Drugglutamin

CIZ1 FOXP2 NCOR1 GLG1

2.49e-04461164CID000000738
DrugCeforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A

CIZ1 MED15 NCOR1

3.00e-041911635351_DN
DrugTracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A

MED15 POU2F1 MRTFA

3.05e-041921632919_DN
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A

CIZ1 MED15 GLG1

3.10e-041931634322_UP
Drugchlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A

NCOR1 GLG1 MINK1

3.14e-041941631217_DN
DrugDimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A

NCOR1 MRTFA NOS1AP

3.14e-041941635450_DN
DrugPyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A

CIZ1 MED15 NCOR1

3.14e-041941631759_UP
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A

NCOR1 GLG1 MRTFA

3.14e-041941631628_UP
DrugIsocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A

MRTFA MINK1 NOS1AP

3.19e-041951634706_DN
DrugGlycocholic acid [475-31-0]; Down 200; 8.6uM; HL60; HT_HG-U133A

GLG1 MRTFA MINK1

3.19e-041951632454_DN
DrugLidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HT_HG-U133A

CIZ1 MINK1 NOS1AP

3.24e-041961634596_UP
DrugGallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A

MRTFA MINK1 NOS1AP

3.24e-041961632221_UP
DrugOxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A

CIZ1 MINK1 NOS1AP

3.24e-041961636469_DN
DrugApomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HG-U133A

CIZ1 NCOR1 MINK1

3.24e-041961631923_UP
DrugIsosorbide dinitrate [87-33-2]; Down 200; 17uM; HL60; HT_HG-U133A

GLG1 MRTFA MINK1

3.24e-041961632183_DN
DrugBenzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A

GLG1 MRTFA MINK1

3.24e-041961631679_DN
DrugVincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A

NCOR1 GLG1 MINK1

3.24e-041961632367_DN
DrugKynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A

CIZ1 MRTFA NOS1AP

3.24e-041961635276_DN
DrugBezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A

GLG1 MINK1 NOS1AP

3.29e-041971632630_UP
DrugCP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A

CIZ1 MRTFA NOS1AP

3.29e-041971637522_DN
DrugHydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A

CIZ1 MED15 MINK1

3.29e-041971632889_UP
DrugCefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A

MRTFA MINK1 NOS1AP

3.29e-041971633426_UP
Drugradicicol; Up 200; 0.1uM; PC3; HG-U133A

CIZ1 GLG1 MINK1

3.29e-04197163484_UP
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A

GLG1 MRTFA MINK1

3.29e-041971631669_UP
DrugOrnidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A

GLG1 MINK1 NOS1AP

3.29e-041971635483_UP
DrugEthamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A

MED15 MRTFA MINK1

3.29e-041971637021_UP
DrugPenbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A

NCOR1 GLG1 MINK1

3.29e-041971637476_DN
DrugDisopyramide [3737-09-5]; Down 200; 11.8uM; PC3; HT_HG-U133A

POU2F1 MRTFA MINK1

3.29e-041971637276_DN
DrugSulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A

CIZ1 NCOR1 MRTFA

3.29e-041971635843_UP
DrugNeomycin sulfate [1405-10-3]; Up 200; 4.2uM; MCF7; HT_HG-U133A

POU6F2 MRTFA MINK1

3.29e-041971632229_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

MED15 MRTFA MINK1

3.29e-041971633566_DN
DrugMimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A

CIZ1 KMT2D MRTFA

3.29e-041971636703_UP
DrugPentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A

GLG1 MRTFA MINK1

3.34e-041981632305_DN
DrugEtofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A

CIZ1 MED15 NCOR1

3.34e-041981635467_DN
DrugTrolox [53188-07-1]; Down 200; 16uM; PC3; HT_HG-U133A

MED15 MRTFA MINK1

3.34e-041981637304_DN
DrugTremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A

CIZ1 MED15 MINK1

3.34e-041981631579_DN
DrugBuflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; PC3; HT_HG-U133A

POU6F2 KMT2D NOS1AP

3.34e-041981634258_UP
DrugNaftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A

CIZ1 NCOR1 GLG1

3.34e-041981637032_DN
DrugNisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A

GLG1 MRTFA NOS1AP

3.34e-041981636496_UP
DrugFlecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A

CIZ1 MRTFA MINK1

3.34e-041981633843_DN
DrugNimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A

POU6F2 MRTFA MINK1

3.34e-041981637024_UP
DrugTetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HT_HG-U133A

CIZ1 MRTFA MINK1

3.34e-041981632489_UP
DrugNadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A

CIZ1 MRTFA NOS1AP

3.34e-041981634139_DN
DrugIsoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; HL60; HG-U133A

POU2F1 GLG1 PHF21A

3.34e-041981631985_UP
DrugVibativ

GLG1 MRTFA

3.38e-0439162CID003081362
DrugMonocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A

MRTFA MINK1 NOS1AP

3.39e-041991636771_UP
DrugPargyline hydrochloride [306-07-0]; Up 200; 20.4uM; MCF7; HT_HG-U133A

MED15 MINK1 NOS1AP

3.39e-041991637016_UP
DrugTiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A

MED15 POU2F1 MINK1

3.39e-041991637311_DN
DrugRimexolone [49697-38-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A

NCOR1 GLG1 MRTFA

3.39e-041991635517_DN
DrugTorsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A

GLG1 MRTFA MINK1

3.39e-041991632956_UP
DrugMetoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; HL60; HT_HG-U133A

POU6F2 KMT2D NOS1AP

3.39e-041991632543_UP
Drug(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A

CIZ1 KMT2D MRTFA

3.39e-041991636444_UP
DrugPiperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A

MRTFA MINK1 NOS1AP

3.39e-041991633845_DN
DrugMinocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A

NCOR1 GLG1 MRTFA

3.39e-041991635496_DN
DrugEpivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A

CIZ1 POU6F2 MINK1

3.44e-042001636838_UP
DrugAC1L1H12

GLG1 MRTFA

4.31e-0444162CID000003929
DrugMerrem

MRTFA MINK1

5.56e-0450162CID000060706
DrugAcetazolamide

POU2F1 GLG1

6.73e-0455162ctd:D000086
Drugsodium sulbactam

MRTFA MINK1

6.97e-0456162CID000005316
Diseaseeye colour measurement

FOXP2 MYOCD NOS1AP

2.51e-04218173EFO_0009764
Diseaseschizophrenia (is_implicated_in)

MED15 FOXP2

9.14e-0478172DOID:5419 (is_implicated_in)
Diseaseopioid use disorder

FOXP2 POU6F2

1.53e-03101172EFO_0010702
DiseaseBladder Neoplasm

NCOR1 KMT2D

2.90e-03140172C0005695
DiseaseMalignant neoplasm of urinary bladder

NCOR1 KMT2D

2.94e-03141172C0005684
Diseasetrauma exposure measurement

FOXP2 POU6F2

4.34e-03172172EFO_0010703
Diseasevital capacity

ZNF853 FAM157B NCOR1 POU6F2

4.71e-031236174EFO_0004312
Diseaseneutrophil percentage of leukocytes

GLG1 MRTFA MINK1

4.82e-03610173EFO_0007990
DiseaseProstatic Neoplasms

CIZ1 NCOR1 KMT2D

4.95e-03616173C0033578
DiseaseMalignant neoplasm of prostate

CIZ1 NCOR1 KMT2D

4.95e-03616173C0376358
Diseaseuterine fibroid

MYOCD MRTFA

5.76e-03199172EFO_0000731
Diseasereaction time measurement

FOXP2 KMT2D PHF21A

5.94e-03658173EFO_0008393

Protein segments in the cluster

PeptideGeneStartEntry
LHLQLLQQQQQQQQQ

FOXP2

146

O15409
TQLQLQQVALQQQQQ

MED15

151

Q96RN5
TAQQQPLQQLQQQQQ

PHF21A

86

Q96BD5
FLQLQILSQQQQQQQ

MYOCD

296

Q8IZQ8
LQQLQQLQQQNLNLQ

POU2F1

176

P14859
LPQSSQLQQQQQQQQ

GLG1

66

Q92896
QQQQQQQQQQLDLLF

FAM157B

76

P0CG42
LQQLLQQQQQQTQVA

NOS1AP

296

O75052
QLQQQQQQQQLQGAE

FMN2

216

Q9NZ56
SEALKQQQQLQQQQQ

MINK1

366

Q8N4C8
LKSLQQQQQQQQLQK

MINK1

476

Q8N4C8
NSQLQQLQLQLQQQQ

POU6F2

176

P78424
SQASQLLQQQQQQQL

NCOR1

51

O75376
QQLFLQLQILNQQQQ

MRTFA

266

Q969V6
QQQQDNLSQQLGNSN

CLEC12B

86

Q2HXU8
QLQQLQQQQLQQQQL

CIZ1

16

Q9ULV3
QQQQLQQQQLLQLQQ

CIZ1

26

Q9ULV3
QQQQLLQLQQLLQQS

CIZ1

31

Q9ULV3
LQQQQLLQQQEQLQQ

ZNF853

211

P0CG23
QQQQQLLLLQQQGQL

ZNF853

236

P0CG23
QQGQLQQQLLQQQQA

ZNF853

246

P0CG23
QQQLLQQQQAQLQQQ

ZNF853

251

P0CG23
QQQQAQLQQQLLEQQ

ZNF853

256

P0CG23
QQLLLQQQEQLQQQQ

ZNF853

276

P0CG23
LSAQLQPAQQQQQQQ

KMT2D

3266

O14686
SLQQLQQQQQLQQQQ

KMT2D

3896

O14686